ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

MDIC Launches Digital Health Initiative

The Medical Device Innovation Consortium (MDIC) announced today the launch of its Digital Health initiative. The scope of digital health-related efforts crosses over several existing programs at MDIC, including Data Science and Technology, Clinical Science, Health Economics and Patient Value, and NESTcc. This launch of the new Digital Health initiative recognizes the convergence of connectivity, information, and software of these active programs and provides an opportunity to focus additional efforts in Software as a Medical Device, Software in a Medical Device, Mobile Medical Application, Interoperability, Wireless Medical Devices, Patient-Generated Health Data, and In-silico validation/modeling.

“The launch of this new initiative reflects our commitment to adapting to the evolution of the medical device ecosystem. We are eager to work with our members and partners to advance innovation and integration of digital health technologies into healthcare decision-making,” said Pamela Goldberg, MDIC President and CEO.

Earlier this year, MDIC hosted a webinar with experts from FDA, a consumer electronics and fitness firm, a medical device manufacturer as well as patient advocates to discuss the existing regulatory framework for digital health, key considerations for patients and healthcare providers, and implications for the future of digital health innovation. The Digital Health working group has identified 5 initial workstreams to complement FDA’s efforts to develop an innovative regulatory pathway for software that is tailored to its unique and iterative nature, including leveraging the learnings from the FDA pre-cert pilot program.

"As digital health technologies are increasingly becoming an integral part of medical devices, I am excited to see that MDIC is launching this new initiative which is well poised and will drive synergy and advance this field,” said Bakul Patel, Director of FDA’s Digital Health Center of Excellence.

The initial workstreams are:

  • Change Control
  • Excellence Appraisal
  • Review Determination
  • Streamlined Premarket Review
  • Evidence Generation, including Real-World Data (RWD) Collection and use of Real-World Evidence (RWE) such as Patient Generated Data and Computer Modeling & Simulation

Each of these workstreams comprises short- and long-term goals which are detailed further in the Digital Health webinar. Learn more about the initiative and how to get involved here.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) focuses on advancing medical device regulatory science throughout the total product lifecycle. MDIC’s mission is to leverage its unique position as the only public-private partnership of its kind to transform health care into human care. Collaborating with our partners to advance science, we enable medical technology to shape the world we want to live in and make that world possible by shortening the path from innovation to safety to access. For more information, visit http://www.mdic.org.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.77
-0.80 (-0.38%)
AAPL  255.92
+0.29 (0.11%)
AMD  217.50
+7.29 (3.47%)
BAC  49.38
+0.11 (0.22%)
GOOG  294.46
-0.44 (-0.15%)
META  574.46
-4.77 (-0.82%)
MSFT  373.46
+4.09 (1.11%)
NVDA  177.39
+1.64 (0.93%)
ORCL  146.38
+1.15 (0.79%)
TSLA  360.59
-20.67 (-5.42%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.